One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

The FDA said it's taking action to protect patients from unapproved animal-derived thyroid medications and expressed concern over the use of unapproved GLP-1 receptor agonists for weight loss, such as ...

For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a ...

The obesity market still only has two clear leaders with approved GLP-1 medications, and frontrunners Eli Lilly and Novo ...

A company that has Donald Trump Jr. on its board debuted a new service to help pharmaceutical companies launch direct sales ...

People who took the daily pill orforglipron lost 12 percent of body weight on average after 72 weeks, according to clinical ...

Drugmaker Eli Lilly says their oral, daily GLP-1 pill, orforglipron, may offer similar weight loss results as weekly GLP-1 ...

The product is viewed by the CPG giant as a “one-of-a-kind opportunity” to help consumers rebuild or maintain muscle they ...

Discover how GLP-1 medications and the MAHA movement are driving protein consumption and creating new opportunities for ...

Axios Visuals Louisiana women are more likely to be prescribed GLP-1 weight-loss drugs than the state's men, new data shows. Why it matters: This is another cultural moment when women, especially ...

So after someone taking a GLP-1 eats, “food just sits there longer,” helping them to feel fuller faster, explains Bailey. Heavy, dense foods, including meat and other proteins, already take ...

GLP-1 weight-loss drugs have already taken the Europe storm, altering consumer eating habits. Even the eating habits of GLP-1 ...